Obama's budget shortens biologic exclusivity, cuts drug spending

04/11/2013 | Medical Marketing & Media · In-PharmaTechnologist.com

President Barack Obama's budget proposal would reduce biologic exclusivity from 12 years to seven, and it includes more than $160 billion in reduced spending that affects drugmakers. The plan would increase discounts for branded medications under Medicare Part D and reduce prices for drugs for people eligible for both Medicare and Medicaid.

View Full Article in:

Medical Marketing & Media · In-PharmaTechnologist.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT